Unique ID issued by UMIN | UMIN000022710 |
---|---|
Receipt number | R000026162 |
Scientific Title | A Randomized, Multicenter, Repeat-Dose Study of Intravenous Acetaminophen With Epidural Analgesia for the Treatment of Pain After Gastrectomy |
Date of disclosure of the study information | 2016/06/12 |
Last modified on | 2016/12/12 21:43:06 |
A Randomized, Multicenter, Repeat-Dose Study of
Intravenous Acetaminophen With Epidural Analgesia for
the Treatment of Pain After Gastrectomy
A Randomized Study of Intravenous Acetaminophen for
the Pain After Gastrecotmy
A Randomized, Multicenter, Repeat-Dose Study of
Intravenous Acetaminophen With Epidural Analgesia for
the Treatment of Pain After Gastrectomy
A Randomized Study of Intravenous Acetaminophen for
the Pain After Gastrecotmy
Japan |
gastric cancer
Gastrointestinal surgery |
Malignancy
NO
The aim of this study is to evaluate the analgesic efficacy of repeated doses of intravenous acetaminophen with epidural analgesia compared with epidural analgesia alone over 48 hours in subjects with moderate to severe pain after distal gastrecomty for gastric cancer.
Efficacy
The number of requiring rescue analgesics of edidural analgesia after surgery for 48 hours
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine |
intravenous acetaminophen(1000mg) for every 6 hours
for 72 postoperative hours in conjunction with epidural
analgesia after distal gastrectomy
epidural analgesia as standard treatment after distal
gastrectomy
20 | years-old | <= |
Not applicable |
Male and Female
1) Histologically proven adenocarcinoma of the stomach
2) Surgically resectable tumor (cT1-4a, N0-3b, M0) by
distal gastrectomy
3) Age 20 > years
4) ECOG performance status 0 or 1.
5) No prior treatment of chemotherapy or radiation
therapy against any other malignancies.
6) Cases with adequately maintained organ functions and
fullfilling the following conditions within 8 weeks
before registration.
WBC>3000
Plt>100000
AST<100
ALT<100
Total bilrbin<2.0mg/dL
Serum creatinine<1.5mg/dL
7) Written informed consent
1) Synchronous or metachronous (within 5 years)
malignancies other than carcinoma in situ.
2) Inappropriate for epidural anesthesia
3) Infectious disease with a systemic therapy indicated.
4) Body temperature of 38C or more.
5) History of hypersensitivity of acetaminophen
6) History of hypersensitivity of aspirin-induced asthma
7) Severe mental disease.
8) Continuous systemic steroid therapy.
9) Unstable angina pectoris or history of myocardial
infarction within 6 months.
10) Uncontrollable hypertension.
11) Uncontrollable diabetes mellitus
12) Severe respiratory disease requiring continuous
oxygen therapy.
13) Women during pregnancy or breast feeding.
14) Judged inappropriate by the investigators
90
1st name | |
Middle name | |
Last name | Sachio Fushida |
Digestive Disease Support Organization (DDSO)
Gastroenterologic surgery
35-1, Yonemaru-machi, Kanazawa, Ishikawa 921-8004, Japan
076-265-2000
junkino0416@gmail.com
1st name | |
Middle name | |
Last name | Jun Kinoshita |
Digestive Disease Support Organization (DDSO)
Gastroenterologic surgery
35-1, Yonemaru-machi, Kanazawa, Ishikawa 921-8004, Japan
076-265-2000
junkino0416@gmail.com
Digestive Disease Support Organization (DDSO)
Digestive Disease Support Organization (DDSO)
Other
NO
2016 | Year | 06 | Month | 12 | Day |
Unpublished
Enrolling by invitation
2016 | Year | 06 | Month | 12 | Day |
2016 | Year | 06 | Month | 20 | Day |
2016 | Year | 06 | Month | 12 | Day |
2016 | Year | 12 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026162